Challenge the Buyout: Ademi & O’Reilly, LLP Investigates Whether Rosetta Resources Inc. Has Obtained a Fair Price in Its Sale to Noble Energy, Inc.


MILWAUKEE, May 11, 2015 (GLOBE NEWSWIRE) -- We are investigating the Board of Directors of Rosetta for possible breaches of fiduciary duty and other violations of state law in connection with the sale of Rosetta to Noble Energy.

Click here to learn how to join the action: http://www.ademilaw.com/case/rosetta or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

Rosetta’s long-term financial outlook is positive and yet shareholders will receive only equivalent of $26.62 per share. Noble Energy is well aware of Rosetta’s improving financial metrics and is purchasing Rosetta at a substantial discount. The merger agreement unreasonably limits prospective bids by (i) prohibiting solicitation of any further bids, and (ii) imposing a termination penalty should Rosetta receive and accept a superior bid. Rosetta’s insiders and their affiliates will receive millions of dollars in the transaction on terms not available to non-insider shareholders. These insiders can unduly influence a sale of Rosetta not necessarily in the best interests of non-insider shareholders. In light of these facts, our investigation centers on the conduct of Rosetta’s Board of Directors, who have unanimously approved the transaction, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Rosetta given its current financial condition and prospects. 

If you own shares of Rosetta and wish to obtain additional information, please contact Guri Ademi either at gademi@ademilaw.com or toll-free: 866-264-3995, http://www.ademilaw.com/case/rosetta.                                  

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country.  For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.



            

Contact Data